Mass Tort Attorneys
We Believe in You
We've always believed that one person can make a difference in the world-that one person's story matters even if it's a lone voice against the powerful tobacco industry, a big drug company, or the producers of medical implants and devices. At Robins Kaplan LLP every mass tort attorney understands the significance of your experience. We remain dedicated to helping you and your family overcome an unexpected medical problem.
We Make It Right
We know that the power of a single story-as told by many different voices-can create a chorus that leads to a greater truth. Our work has made history. From our groundbreaking lawsuit against the tobacco industry to the representation of over 500 women in the Dalkon Shield cases, to the cases we are working on, many of our mass tort lawyers have been listed as Super Lawyers and in Best Lawyers in America and are experienced in breaking judicial logjams, making industry safer for consumers everywhere and, most importantly, giving voice to our clients.
We Hear You
We are careful listeners and your story is important to us. Our clients do not walk alone. We guide them through the ins-and-outs of their case and help them understand the legal landscape as well as each step along the way. Our on-staff legal nurse consultants are available to answer your questions and listen to your concerns as you determine what to do next. If you think you or a loved one has been injured by a defective drug or medical device, we are interested in hearing what you have to say.
To contact a mass tort attorney for a free case evaluation, please call 1.800.553.9910 (toll-free) or use the form on the right.
Articles and News
Robins Kaplan LLP Attorney Holly Dolejsi Appointed to Plaintiffs’ Steering Committee for the Invokana Multidistrict Litigation
Judge Brian R. Martinotti of the District of New Jersey entered an order on Jan. 24 appointing Holly Dolejsi to the Plaintiffs’ Steering Committee for the Invokana multidistrict litigation.
Robins Kaplan Partners Gary Wilson, Tara Sutton, and Munir Meghjee Appointed to Abilify MDL Litigation Leadership
On December 16, 2016, Chief Judge M. Casey Rodgers of the U.S. District Court for the Northern District of Florida appointed three Robins Kaplan LLP partners to the leadership team in the Abilify Compulsivity Cases multi-district litigation.
Contaminated Devices Putting Open-Heart Surgery Patients at Risk
Robins Kaplan LLP is currently investigating claims regarding Sorin Stockert 3T Heater-Cooler Devices.
Stryker® Orthopedics LFIT™ CoCr V40™ Femoral Head Failure Concerns
Robins Kaplan’s Mass Tort Department is currently investigating cases involving another Stryker Orthopedics total hip replacement component, the LFIT™ CoCr V40™ Femoral Head.
FDA warns about impulse-control problems associated with mental health drug Abilify
On May 3, 2016 the FDA warned that compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex have been reported with the use of the antipsychotic drug Abilify.
Kate Jaycox Appointed to Lead Zofran Litigation
In December 2015, the Honorable F. Dennis Saylor IV appointed Robins Kaplan LLP principal Kate Jaycox to the Plaintiffs’ Steering Committee for In Re: Zofran (ondansetron) Products Liability Litigation, MDL 2657.
Abilify Makers Warn of Compulsive Gambling Behavior in Canada But Not in United States
On November 2, 2015, Health Canada issued a Safety Alert advising physicians and patients of an increased risk of pathological gambling on Abilify.
Robins Kaplan LLP Investigates Type 2 Diabetes Drugs and Severe Injuries, Including Ketoacidosis
Invokana and other related type 2 diabetes drugs have been linked to a serious condition known as ketoacidosis.
Consumer Alert: Popular Anti-Nausea Drug Zofran Linked to Birth Defects
Zofran, a drug commonly prescribed for “off label” use during pregnancy, has been linked to defects such as cleft palate and heart malformations.
Robins Kaplan Takes a Leading Role in the Expanding Litigation over Benicar and Severe Gastrointestinal Injuries
Firm's Mass Tort attorneys have taken leadership roles in the recent multidistrict litigation involving Benicar and gastrointestinal injuries.
Study Associating Viagra Use to Melanoma Risks is a Significant Red Flag
Reporting on April 2014 Viagra-Melanoma study showing increased risk of melanoma for men who use Viagra (brand name of the drug sildenafil).
Global Resolution Reached in Lawsuits over Stryker Rejuvenate/ABG II Failed Hips
Global settlement program involving Stryker’s Rejuvenate and ABG II modular hip implants
Law360: "Stryker To Pay $1 To Settle Hip Implant MDL Claims"
Stryker® Orthopedics Recalls its Rejuvenate® and ABGTM II Modular-Neck Hip Stems
Firm’s Mass Tort attorneys are retaining cases involving the recalled Stryker® Orthopedics’ Rejuvenate® and ABG™ II Modular-Neck Hip Stems.
Robins, Kaplan, Miller & Ciresi L.L.P. Client among First to Reach Settlement in Stryker Hip Replacement Lawsuit
In December, a firm client became one of the first in the country to settle their Stryker hip implant lawsuit.
Generic Drug Liability Primer
Explanation of generic drug manufacturer liability in failure to warn cases after Supreme Court’s Mutual Pharmaceutical v. Bartlett decision.
Consumer Alert: Lariam Antimalarial Drug & Permanent Neuropsychological Side Effects
Attorneys at Robins Kaplan LLP are investigating reports of serious neurological and psychiatric side effects associated with mefloquine hydrochloride.
Abilify (aripiprazole) and Compulsive Behavior
As of July 2013, at least eight cases of compulsive gambling in patients taking Abilify have been reported in medical journals by physicians involved in the cases.
FOSAMAX® Femur Fracture Update
In addition to litigation alleging osteonecrosis of the jaw ("ONJ") and musculoskeletal pain arising from FOSAMAX® use, recent studies, reports, and news stories have indicated that long term use of the drug may be linked to atypical femur fractures.
FDA Has Concerns About All Types of Metal-On-Metal Hip Implants
Traditional Metal-on-Metal (MoM) total hip replacement implants consist of a femoral head ball, femoral stem, and an acetabular cup - all made of metal materials. The FDA recommends that any MoM hip patient with pain in the groin, hip, or leg; swelling at or near the hip joint; or a limp or change in walking ability be evaluated by their orthopedic surgeon promptly due to unique risks of MoM implants.
Consumer Alert: Use of GranuFlo® and NaturaLyte® Dialysates Linked to Risk of Cardiac Arrest
GranuFlo® and NaturaLyte® are dialysates used during kidney dialysis to remove wastes from the blood of patients with acute or chronic renal failure. The use of GranuFlo® and NaturaLyte® has been reported in some cases to lead to a blood condition called "alkalosis," which can lead to low blood pressure and even cardiac arrest.
Consumer Alert Update: Zimmer NexGen Flex Knee Implants Litigation
The Zimmer NexGen Flex knee replacement system, manufactured by Zimmer Inc., is marketed as a line of "high-flex" knee implants designed to give knee replacement recipients greater range of motion. However, studies have shown that these high-flex implants can lead to pain, loosening, and instability in the knee, requiring removal and replacement of the implants.
Attorney Kate Jaycox Selected to Serve on American Association for Justice Board of Governors
Robins Kaplan LLP is pleased to announce that Kate Jaycox has been selected to serve on the American Association for Justice (AAJ) Board of Governors.
Tara Sutton to Co-Chair Food, Drug and Medical Device Litigation Conference
The conference, which took place in Minneapolis, was on April 23-24, 2012.
Firm's Mass Tort Practice Receives Tier 1 Rating
For a second year in a row, the Mass Tort group at Robins Kaplan LLP has been recognized as a top tier litigation practice by U.S. News Media Group and Best Lawyers.**
Consumer Alert Update: Imprelis® MDL Created and Information on Imprelis® Claims Program
The DuPont chemical company's Imprelis® herbicide has been linked to the significant damage and death of desirable vegetation including trees, shrubs, and ornamental plants. On August 10, the Environmental Protection Agency (EPA) ordered DuPont to halt the sale, use, and distribution of the chemical.
Avandia Consumer Alert: More Negative Data Emerges as FDA Advisory Board Recommends Stronger Warnings
Avandia is a drug used to control blood sugar for Type 2 diabetics, but has been associated with multiple safety issues, including heart attacks, congestive heart failure, strokes and bone fractures.